Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.
Open | $25.150 |
Close | - |
Volume / Avg. | 148.861K / 491.760K |
Day Range | 24.999 - 26.270 |
52 Wk Range | 23.140 - 35.560 |
Market Cap | $1.199B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 21.18% |
Days to Cover | 18.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mirum Pharmaceuticals (NASDAQ: MIRM) through any online brokerage.
Other companies in Mirum Pharmaceuticals’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Prothena Corp (NASDAQ:PRTA).
The latest price target for Mirum Pharmaceuticals (NASDAQ: MIRM) was reported by Morgan Stanley on Friday, May 10, 2024. The analyst firm set a price target for 53.00 expecting MIRM to rise to within 12 months (a possible 108.37% upside). 36 analyst firms have reported ratings in the last year.
The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $25.435 last updated Today at May 13, 2024 at 12:55 PM EDT.
There are no upcoming dividends for Mirum Pharmaceuticals.
Mirum Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Mirum Pharmaceuticals.
Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.